{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:53:50Z","timestamp":1783979630972,"version":"3.55.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide, particularly among individuals under the age of 45. It is a complex, and heterogeneous disease with a multifaceted pathophysiology that remains to be elucidated. Metabolomics has the potential to identify metabolic pathways and unique biochemical profiles associated with TBI. Herein, we employed a longitudinal metabolomics approach to study TBI in a weight drop mouse model to reveal metabolic changes associated with TBI pathogenesis, severity, and secondary injury. Using proton nuclear magnetic resonance (<jats:sup>1<\/jats:sup>H NMR) spectroscopy, we biochemically profiled post-mortem brain from mice that suffered mild TBI (N\u2009=\u200925; 13 male and 12 female), severe TBI (N\u2009=\u200924; 11 male and 13 female) and sham controls (N\u2009=\u200916; 11 male and 5 female) at baseline, day 1 and day 7 following the injury. <jats:sup>1<\/jats:sup>H NMR-based metabolomics, in combination with bioinformatic analyses, highlights a few significant metabolites associated with TBI severity and perturbed metabolism related to the injury. We report that the concentrations of <jats:italic>taurine<\/jats:italic>, <jats:italic>creatinine<\/jats:italic>, <jats:italic>adenine<\/jats:italic>, <jats:italic>dimethylamine<\/jats:italic>, <jats:italic>histidine<\/jats:italic>, <jats:italic>N-Acetyl aspartate<\/jats:italic>, and <jats:italic>glucose 1-phosphate<\/jats:italic> are all associated with TBI severity. Longitudinal metabolic observation of brain tissue revealed that mild TBI and severe TBI lead distinct metabolic profile changes. A multi-class model was able to classify the severity of injury as well as time after TBI with estimated 86% accuracy. Further, we identified a high degree of correlation between respective hemisphere metabolic profiles (r\u2009&gt;\u20090.84, p\u2009&lt;\u20090.05, Pearson correlation). This study highlights the metabolic changes associated with underlying TBI severity and secondary injury. While comprehensive, future studies should investigate whether: (a) the biochemical pathways highlighted here are recapitulated in the brain of TBI sufferers and (b) if the panel of biomarkers are also as effective in less invasively harvested biomatrices, for objective and rapid identification of TBI severity and prognosis.<\/jats:p>","DOI":"10.1038\/s41598-023-48539-x","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T19:02:35Z","timestamp":1702580555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The longitudinal biochemical profiling of TBI in a drop weight model of TBI"],"prefix":"10.1038","volume":"13","author":[{"given":"Ali","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Liraz-Zaltsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Shohami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juozas","family":"Gordevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Ker\u0161evi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray O.","family":"Bahado-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart F.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"7872","key":"48539_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale, G. & Jennett, B. Assessment of coma and impaired consciousness. A practical scale. Lancet 2(7872), 81\u201384 (1974).","journal-title":"Lancet"},{"issue":"5","key":"48539_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.apmr.2004.09.026","volume":"86","author":"W Wei","year":"2005","unstructured":"Wei, W. et al. Mental illness, traumatic brain injury, and medicaid expenditures. Arch. Phys. Med. Rehabil. 86(5), 905\u2013911 (2005).","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"3\u20134","key":"48539_CR3","first-page":"103","volume":"20","author":"KT Ragnarsson","year":"2002","unstructured":"Ragnarsson, K. T. Results of the NIH consensus conference on\" rehabilitation of persons with traumatic brain injury\". Restorat. Neurol. Neurosci. 20(3\u20134), 103\u2013108 (2002).","journal-title":"Restorat. Neurol. Neurosci."},{"key":"48539_CR4","volume-title":"Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","author":"J Lifshitz","year":"2015","unstructured":"Lifshitz, J. Experimental CNS trauma: A general overview of neurotrauma research. In Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects (ed. Kobeissy, F.) (CRC Press, 2015)."},{"issue":"1","key":"48539_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1227\/NEU.0000000000000575","volume":"76","author":"AI Maas","year":"2015","unstructured":"Maas, A. I. et al. Collaborative European NeuroTrauma effectiveness research in traumatic brain injury (CENTER-TBI): A prospective longitudinal observational study. Neurosurgery 76(1), 67\u201380 (2015).","journal-title":"Neurosurgery"},{"issue":"12","key":"48539_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","volume":"16","author":"AIR Maas","year":"2017","unstructured":"Maas, A. I. R. et al. Traumatic brain injury: Integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 16(12), 987\u20131048 (2017).","journal-title":"Lancet Neurol."},{"issue":"4","key":"48539_CR7","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","volume":"130","author":"MC Dewan","year":"2018","unstructured":"Dewan, M. C. et al. Estimating the global incidence of traumatic brain injury. J. Neurosurg. 130(4), 1080\u20131097 (2018).","journal-title":"J. Neurosurg."},{"issue":"3","key":"48539_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ejpn.2019.01.009","volume":"23","author":"M Olsen","year":"2019","unstructured":"Olsen, M. et al. Incidence and mortality of moderate and severe traumatic brain injury in children: A ten year population-based cohort study in Norway. Eur. J. Paediatr. Neurol. 23(3), 500\u2013506 (2019).","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"11","key":"48539_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AI Maas","year":"2022","unstructured":"Maas, A. I. et al. Traumatic brain injury: Progress and challenges in prevention, clinical care, and research. Lancet Neurol. 21(11), 1004\u20131060 (2022).","journal-title":"Lancet Neurol."},{"issue":"10","key":"48539_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"VL Feigin","year":"2021","unstructured":"Feigin, V. L. et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20(10), 795\u2013820 (2021).","journal-title":"Lancet Neurol."},{"issue":"3","key":"48539_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/PRM-2012-0214","volume":"5","author":"B Kurowski","year":"2012","unstructured":"Kurowski, B., Martin, L. J. & Wade, S. L. Genetics and outcomes after traumatic brain injury (TBI): What do we know about pediatric TBI? J. Pediatr. Rehabil. Med. 5(3), 217\u2013231 (2012).","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"48539_CR12","volume-title":"Traumatic Brain Injury-Related Hospitalizations and Deaths by Age Group, Sex, and Mechanism of Injury: United States 2016\/2017","author":"AB Peterson","year":"2021","unstructured":"Peterson, A. B., Zhou, H., Thomas, K. E. & Daugherty, J. Traumatic Brain Injury-Related Hospitalizations and Deaths by Age Group, Sex, and Mechanism of Injury: United States 2016\/2017 (National Center for Injury and Control, 2021)."},{"issue":"27","key":"48539_CR13","first-page":"549","volume":"62","author":"DW Wright","year":"2013","unstructured":"Wright, D. W., Kellermann, A., McGuire, L. C., Chen, B. & Popovic, T. CDC grand rounds: reducing severe traumatic brain injury in the United States. Morb. Mortal Wkly. Rep. 62(27), 549\u2013552 (2013).","journal-title":"Morb. Mortal Wkly. Rep."},{"issue":"3","key":"48539_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11306-016-0957-1","volume":"12","author":"RO Bahado-Singh","year":"2016","unstructured":"Bahado-Singh, R. O. et al. Identification of candidate biomarkers of brain damage in a mouse model of closed head injury: A metabolomic pilot study. Metabolomics 12(3), 42 (2016).","journal-title":"Metabolomics"},{"issue":"1","key":"48539_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/JMN:16:1:33","volume":"16","author":"AE Mautes","year":"2001","unstructured":"Mautes, A. E. et al. Changes in regional energy metabolism after closed head injury in the rat. J. Mol. Neurosci. 16(1), 33\u201339 (2001).","journal-title":"J. Mol. Neurosci."},{"key":"48539_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng, S. Y. & Lee, A. Y. W. Traumatic brain injuries: Pathophysiology and potential therapeutic targets. Front. Cell Neurosci. 13, 528 (2019).","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"48539_CR17","doi-asserted-by":"publisher","first-page":"e0267682","DOI":"10.1371\/journal.pone.0267682","volume":"17","author":"HA Weisz","year":"2022","unstructured":"Weisz, H. A. et al. Mechanistic insights gained from cell and molecular analysis of the neuroprotective potential of bioactive natural compounds in an immortalized hippocampal cell line. PLoS ONE 17(6), e0267682 (2022).","journal-title":"PLoS ONE"},{"key":"48539_CR18","doi-asserted-by":"publisher","first-page":"108400","DOI":"10.1016\/j.neuropharm.2020.108400","volume":"183","author":"S Manivannan","year":"2021","unstructured":"Manivannan, S. et al. Neurogenesis after traumatic brain injury\u2014The complex role of HMGB1 and neuroinflammation. Neuropharmacology 183, 108400 (2021).","journal-title":"Neuropharmacology"},{"issue":"9","key":"48539_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa, K. et al. Traumatic brain injury: Mechanistic insight on pathophysiology and potential therapeutic targets. J. Mol. Neurosci. 71(9), 1725\u20131742 (2021).","journal-title":"J. Mol. Neurosci."},{"key":"48539_CR20","doi-asserted-by":"publisher","first-page":"147225","DOI":"10.1016\/j.brainres.2020.147225","volume":"1753","author":"JL Weaver","year":"2021","unstructured":"Weaver, J. L. The brain-gut axis: A prime therapeutic target in traumatic brain injury. Brain Res. 1753, 147225 (2021).","journal-title":"Brain Res."},{"issue":"6","key":"48539_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/neu.2008.0794","volume":"26","author":"S Margulies","year":"2009","unstructured":"Margulies, S. & Hicks, R. Combination therapies for traumatic brain injury: Prospective considerations. J. Neurotrauma 26(6), 925\u2013939 (2009).","journal-title":"J. Neurotrauma"},{"key":"48539_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnene.2013.00008","volume":"5","author":"B Bartnik-Olson","year":"2013","unstructured":"Bartnik-Olson, B. et al. Insights into the metabolic response to traumatic brain injury as revealed by 13C NMR spectroscopy. Front. Neuroenerget. 5, 8 (2013).","journal-title":"Front. Neuroenerget."},{"issue":"10","key":"48539_CR23","doi-asserted-by":"publisher","first-page":"e0206481","DOI":"10.1371\/journal.pone.0206481","volume":"13","author":"EW Baker","year":"2018","unstructured":"Baker, E. W. et al. Scaled traumatic brain injury results in unique metabolomic signatures between gray matter, white matter, and serum in a piglet model. PLoS ONE 13(10), e0206481 (2018).","journal-title":"PLoS ONE"},{"issue":"6","key":"48539_CR24","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1021\/acs.jproteome.8b00068","volume":"17","author":"SR Hogan","year":"2018","unstructured":"Hogan, S. R. et al. Discovery of lipidome alterations following traumatic brain injury via high-resolution metabolomics. J. Proteome Res. 17(6), 2131\u20132143 (2018).","journal-title":"J. Proteome Res."},{"issue":"11","key":"48539_CR25","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1089\/neu.2004.21.1553","volume":"21","author":"LE Pelinka","year":"2004","unstructured":"Pelinka, L. E. et al. GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. J. Neurotrauma 21(11), 1553\u20131561 (2004).","journal-title":"J. Neurotrauma"},{"issue":"9","key":"48539_CR26","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/clinchem\/35.9.1942","volume":"35","author":"A Usui","year":"1989","unstructured":"Usui, A. et al. S-100ao protein in blood and urine during open-heart surgery. Clin. Chem. 35(9), 1942\u20131944 (1989).","journal-title":"Clin. Chem."},{"issue":"20","key":"48539_CR27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","volume":"75","author":"PE Vos","year":"2010","unstructured":"Vos, P. E. et al. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 75(20), 1786\u20131793 (2010).","journal-title":"Neurology"},{"issue":"10","key":"48539_CR28","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/01.STR.28.10.1956","volume":"28","author":"U Missler","year":"1997","unstructured":"Missler, U. et al. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28(10), 1956\u20131960 (1997).","journal-title":"Stroke"},{"issue":"5","key":"48539_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/02688699647104","volume":"10","author":"SA Ross","year":"1996","unstructured":"Ross, S. A. et al. Neuron-specific enolase as an aid to outcome prediction in head injury. Br. J. Neurosurg. 10(5), 471\u2013476 (1996).","journal-title":"Br. J. Neurosurg."},{"issue":"7216","key":"48539_CR30","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/4551054a","volume":"455","author":"JK Nicholson","year":"2008","unstructured":"Nicholson, J. K. & Lindon, J. C. Systems biology: Metabonomics. Nature 455(7216), 1054\u20131056 (2008).","journal-title":"Nature"},{"issue":"6","key":"48539_CR31","doi-asserted-by":"publisher","first-page":"e0129735","DOI":"10.1371\/journal.pone.0129735","volume":"10","author":"SA Sheth","year":"2015","unstructured":"Sheth, S. A. et al. Targeted lipid profiling discovers plasma biomarkers of acute brain injury. PLoS ONE 10(6), e0129735 (2015).","journal-title":"PLoS ONE"},{"issue":"9","key":"48539_CR32","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/nprot.2009.148","volume":"4","author":"MA Flierl","year":"2009","unstructured":"Flierl, M. A. et al. Mouse closed head injury model induced by a weight-drop device. Nat. Protoc. 4(9), 1328\u20131337 (2009).","journal-title":"Nat. Protoc."},{"issue":"11","key":"48539_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14737159.2018.1535904","volume":"18","author":"A Regner","year":"2018","unstructured":"Regner, A. et al. Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev. Mol. Diagn. 18(11), 925\u2013938 (2018).","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"4","key":"48539_CR34","first-page":"798","volume":"52","author":"T Ingebrigtsen","year":"2002","unstructured":"Ingebrigtsen, T. & Romner, B. Biochemical serum markers of traumatic brain injury. J. Trauma 52(4), 798\u2013808 (2002).","journal-title":"J. Trauma"},{"key":"48539_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ebiom.2016.09.024","volume":"12","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2016","unstructured":"Gonz\u00e1lez-Dom\u00ednguez, R. Medium-chain fatty acids as biomarkers of mitochondrial dysfunction in traumatic brain injury. EBioMedicine 12, 8\u20139 (2016).","journal-title":"EBioMedicine"},{"key":"48539_CR36","doi-asserted-by":"publisher","first-page":"882487","DOI":"10.3389\/fmolb.2022.882487","volume":"9","author":"S Moco","year":"2022","unstructured":"Moco, S. Studying metabolism by NMR-based metabolomics. Front. Mol. Biosci. 9, 882487 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"48539_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/acs.analchem.6b04420","volume":"89","author":"GA Nagana Gowda","year":"2017","unstructured":"Nagana Gowda, G. A. & Raftery, D. Recent advances in NMR-based metabolomics. Anal. Chem. 89(1), 490\u2013510 (2017).","journal-title":"Anal. Chem."},{"issue":"8","key":"48539_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/metabo12080678","volume":"12","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. NMR and metabolomics\u2014A roadmap for the future. Metabolites 12(8), 678 (2022).","journal-title":"Metabolites"},{"issue":"4","key":"48539_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1021\/acschembio.1c00053","volume":"16","author":"AC Abreu","year":"2021","unstructured":"Abreu, A. C. et al. NMR-based metabolomics approach to explore brain metabolic changes induced by prenatal exposure to autism-inducing chemicals. ACS Chem. Biol. 16(4), 753\u2013765 (2021).","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"48539_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-9-47","volume":"9","author":"M Naccarato","year":"2010","unstructured":"Naccarato, M. et al. Possible anandamide and palmitoylethanolamide involvement in human stroke. Lipids Health Dis. 9(1), 1\u20136 (2010).","journal-title":"Lipids Health Dis."},{"key":"48539_CR41","doi-asserted-by":"publisher","first-page":"645829","DOI":"10.3389\/fneur.2021.645829","volume":"12","author":"ZR Wanner","year":"2021","unstructured":"Wanner, Z. R. et al. Alterations in urine metabolomics following sport-related concussion: A (1)H NMR-based analysis. Front. Neurol. 12, 645829 (2021).","journal-title":"Front. Neurol."},{"issue":"4","key":"48539_CR42","doi-asserted-by":"publisher","first-page":"e93736","DOI":"10.1371\/journal.pone.0093736","volume":"9","author":"J Peng","year":"2014","unstructured":"Peng, J. et al. Establishment of quantitative severity evaluation model for spinal cord injury by metabolomic fingerprinting. PLoS ONE 9(4), e93736 (2014).","journal-title":"PLoS ONE"},{"issue":"7","key":"48539_CR43","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1021\/acs.jproteome.8b00224","volume":"17","author":"SF Graham","year":"2018","unstructured":"Graham, S. F. et al. Biochemical profiling of the brain and blood metabolome in a mouse model of prodromal Parkinson\u2019s disease reveals distinct metabolic profiles. J. Proteome Res. 17(7), 2460\u20132469 (2018).","journal-title":"J. Proteome Res."},{"issue":"9","key":"48539_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","volume":"1862","author":"SF Graham","year":"2016","unstructured":"Graham, S. F. et al. Metabolic signatures of Huntington\u2019s disease (HD): 1H NMR analysis of the polar metabolome in post-mortem human brain. Biochim. Biophys. Acta Mol. Basis Dis. 1862(9), 1675\u20131684 (2016).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"4","key":"48539_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/neu.2007.0452","volume":"25","author":"J Tsenter","year":"2008","unstructured":"Tsenter, J. et al. Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J. Neurotrauma 25(4), 324\u2013333 (2008).","journal-title":"J. Neurotrauma"},{"issue":"7","key":"48539_CR46","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18(7), e3000410 (2020).","journal-title":"PLoS Biol."},{"issue":"5","key":"48539_CR47","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","volume":"176","author":"MT Joy","year":"2019","unstructured":"Joy, M. T. et al. CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury. Cell 176(5), 1143\u20131157 (2019).","journal-title":"Cell"},{"issue":"1","key":"48539_CR48","first-page":"57","volume":"296","author":"L Beni-Adani","year":"2001","unstructured":"Beni-Adani, L. et al. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296(1), 57\u201363 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"48539_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11306-018-1448-3","volume":"14","author":"G Garg","year":"2018","unstructured":"Garg, G. et al. Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: A pilot study. Metabolomics 14(12), 154 (2018).","journal-title":"Metabolomics"},{"issue":"3\u20134","key":"48539_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10858-011-9480-x","volume":"49","author":"P Mercier","year":"2011","unstructured":"Mercier, P. et al. Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra. J. Biomol. NMR 49(3\u20134), 307\u2013323 (2011).","journal-title":"J. Biomol. NMR"},{"issue":"9","key":"48539_CR51","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso, D. et al. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol. 32(9), 896\u2013902 (2014).","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"48539_CR52","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"48539_CR53","first-page":"726","volume":"1","author":"R Kolde","year":"2012","unstructured":"Kolde, R. Pheatmap: Pretty heatmaps. R Package Version 1(2), 726 (2012).","journal-title":"R Package Version"},{"issue":"1","key":"48539_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12859-020-03910-x","volume":"21","author":"S Canzler","year":"2020","unstructured":"Canzler, S. & Hackerm\u00fcller, J. multiGSEA: A GSEA-based pathway enrichment analysis for multi-omics data. BMC Bioinform. 21(1), 561 (2020).","journal-title":"BMC Bioinform."},{"issue":"1","key":"48539_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"48539_CR56","first-page":"060012","volume":"2021","author":"G Korotkevich","year":"2021","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. BioRxiv 2021, 060012 (2021).","journal-title":"BioRxiv"},{"issue":"14","key":"48539_CR57","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo, W. & Brouwer, C. Pathview: An R\/bioconductor package for pathway-based data integration and visualization. Bioinformatics 29(14), 1830\u20131831 (2013).","journal-title":"Bioinformatics"},{"issue":"5","key":"48539_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28(5), 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"48539_CR59","doi-asserted-by":"publisher","first-page":"804261","DOI":"10.3389\/fnins.2022.804261","volume":"16","author":"S Vishweswaraiah","year":"2022","unstructured":"Vishweswaraiah, S. et al. Methylated cytochrome P450 and the solute carrier family of genes correlate with perturbations in bile acid metabolism in Parkinson\u2019s disease. Front. Neurosci. 16, 804261 (2022).","journal-title":"Front. Neurosci."},{"key":"48539_CR60","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnhum.2017.00469","volume":"11","author":"KC Dodd","year":"2017","unstructured":"Dodd, K. C., Nair, V. A. & Prabhakaran, V. Role of the contralesional vs ipsilesional hemisphere in stroke recovery. Front. Hum. Neurosci. 11, 469 (2017).","journal-title":"Front. Hum. Neurosci."},{"issue":"2","key":"48539_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/braincomms\/fcaa208","volume":"2","author":"H Watanabe","year":"2020","unstructured":"Watanabe, H. et al. Ipsilesional versus contralesional postural deficits induced by unilateral brain trauma: A side reversal by opioid mechanism. Brain Commun. 2(2), 208 (2020).","journal-title":"Brain Commun."},{"key":"48539_CR62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4615-0123-7_9","volume":"513","author":"TW Stone","year":"2002","unstructured":"Stone, T. W. Purines and neuroprotection. Adv. Exp. Med. Biol. 513, 249\u2013280 (2002).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"48539_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jnc.13551","volume":"137","author":"EK Jackson","year":"2016","unstructured":"Jackson, E. K. et al. Purines: Forgotten mediators in traumatic brain injury. J. Neurochem. 137(2), 142\u2013153 (2016).","journal-title":"J. Neurochem."},{"key":"48539_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.brainres.2014.01.044","volume":"1555","author":"S Dachir","year":"2014","unstructured":"Dachir, S. et al. Inosine improves functional recovery after experimental traumatic brain injury. Brain Res. 1555, 78\u201388 (2014).","journal-title":"Brain Res."},{"issue":"3","key":"48539_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tips.2004.01.006","volume":"25","author":"G Hask\u00f3","year":"2004","unstructured":"Hask\u00f3, G., Sitkovsky, M. V. & Szab\u00f3, C. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol. Sci. 25(3), 152\u2013157 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"48539_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fneur.2017.00398","volume":"8","author":"JP Posti","year":"2017","unstructured":"Posti, J. P. et al. Metabolomics profiling as a diagnostic tool in severe traumatic brain injury. Front. Neurol. 8, 398 (2017).","journal-title":"Front. Neurol."},{"issue":"2","key":"48539_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/01.WCB.0000103022.98348.24","volume":"24","author":"JP Coles","year":"2004","unstructured":"Coles, J. P. et al. Incidence and mechanisms of cerebral ischemia in early clinical head injury. J. Cereb. Blood Flow Metab. 24(2), 202\u2013211 (2004).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"48539_CR68","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/01.CCM.0000127777.16609.08","volume":"32","author":"DK Menon","year":"2004","unstructured":"Menon, D. K. et al. Diffusion limited oxygen delivery following head injury. Crit. Care Med. 32(6), 1384\u20131390 (2004).","journal-title":"Crit. Care Med."},{"issue":"11","key":"48539_CR69","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1177\/0271678X16666552","volume":"36","author":"GA Dienel","year":"2016","unstructured":"Dienel, G. A., Rothman, D. L. & Nordstr\u00f6m, C. H. Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients. J. Cereb. Blood Flow Metab. 36(11), 1844\u20131864 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"Pt 2","key":"48539_CR70","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/brain\/awq353","volume":"134","author":"I Timofeev","year":"2011","unstructured":"Timofeev, I. et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: A microdialysis study of 223 patients. Brain 134(Pt 2), 484\u2013494 (2011).","journal-title":"Brain"},{"issue":"8","key":"48539_CR71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/neu.2012.2491","volume":"30","author":"CB Jeter","year":"2013","unstructured":"Jeter, C. B. et al. Human mild traumatic brain injury decreases circulating branched-chain amino acids and their metabolite levels. J. Neurotrauma 30(8), 671\u2013679 (2013).","journal-title":"J. Neurotrauma"},{"issue":"1","key":"48539_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/HTR.0000000000000280","volume":"33","author":"B Sharma","year":"2018","unstructured":"Sharma, B., Lawrence, D. W. & Hutchison, M. G. Branched chain amino acids (BCAAs) and traumatic brain injury: A systematic review. J. Head Trauma Rehabil. 33(1), 33\u201345 (2018).","journal-title":"J. Head Trauma Rehabil."},{"issue":"6 Suppl","key":"48539_CR73","doi-asserted-by":"publisher","first-page":"1539s","DOI":"10.1093\/jn\/135.6.1539S","volume":"135","author":"JD Fernstrom","year":"2005","unstructured":"Fernstrom, J. D. Branched-chain amino acids and brain function. J. Nutr. 135(6 Suppl), 1539s\u20131546s (2005).","journal-title":"J. Nutr."},{"issue":"2","key":"48539_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn3407","volume":"14","author":"Y Xiong","year":"2013","unstructured":"Xiong, Y., Mahmood, A. & Chopp, M. Animal models of traumatic brain injury. Nat. Rev. Neurosci. 14(2), 128\u2013142 (2013).","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"48539_CR75","first-page":"535","volume":"8","author":"GG Ecsedi","year":"1986","unstructured":"Ecsedi, G. G. & Vir\u00e1g, S. Accumulation of cholesterol ester in cultured smooth muscle cells of congenital hypercholesterolemic (WHHL) rabbits treated with normal and WHHL rabbit plasma LDL. Methods Find Exp. Clin. Pharmacol. 8(9), 535\u2013542 (1986).","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"issue":"11","key":"48539_CR76","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/jcp.41.11.1233","volume":"41","author":"S Ramskill","year":"1988","unstructured":"Ramskill, S. et al. Enzyme linked immunosorbent assay (ELISA) for cytomegalovirus antibody in donor plasma. J. Clin. Pathol. 41(11), 1233\u20131235 (1988).","journal-title":"J. Clin. Pathol."},{"key":"48539_CR77","first-page":"12","volume":"5","author":"WD Watson","year":"2013","unstructured":"Watson, W. D. et al. Impaired cortical mitochondrial function following TBI precedes behavioral changes. Front. Neuroenerget. 5, 12 (2013).","journal-title":"Front. Neuroenerget."},{"key":"48539_CR78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.expneurol.2015.05.009","volume":"271","author":"TJ Kilbaugh","year":"2015","unstructured":"Kilbaugh, T. J. et al. Mitochondrial bioenergetic alterations after focal traumatic brain injury in the immature brain. Exp. Neurol. 271, 136\u2013144 (2015).","journal-title":"Exp. Neurol."},{"key":"48539_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnins.2015.00112","volume":"9","author":"KL Carpenter","year":"2015","unstructured":"Carpenter, K. L., Jalloh, I. & Hutchinson, P. J. Glycolysis and the significance of lactate in traumatic brain injury. Front. Neurosci. 9, 112 (2015).","journal-title":"Front. Neurosci."},{"key":"48539_CR80","first-page":"077214","volume":"2016","author":"A Sen","year":"2016","unstructured":"Sen, A. et al. Traumatic brain injury causes retention of long introns in metabolic genes via regulation of intronic Histone 3 lysine 36 methylation levels in the sub-acute phase of injury. BioRxiv 2016, 077214 (2016).","journal-title":"BioRxiv"},{"issue":"22","key":"48539_CR81","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.3390\/ijms20225774","volume":"20","author":"G Lazzarino","year":"2019","unstructured":"Lazzarino, G. et al. Pyruvate dehydrogenase and tricarboxylic acid cycle enzymes are sensitive targets of traumatic brain injury induced metabolic derangement. Int. J. Mol. Sci. 20(22), 5774 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"48539_CR82","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11306-016-1044-3","volume":"12","author":"RO Bahado-Singh","year":"2016","unstructured":"Bahado-Singh, R. O. et al. Serum metabolomic markers for traumatic brain injury: A mouse model. Metabolomics 12(6), 100 (2016).","journal-title":"Metabolomics"},{"key":"48539_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneumeth.2016.02.004","volume":"272","author":"A Roux","year":"2016","unstructured":"Roux, A. et al. Mass spectrometry imaging of rat brain lipid profile changes over time following traumatic brain injury. J. Neurosci. Methods 272, 19\u201332 (2016).","journal-title":"J. Neurosci. Methods"},{"issue":"17","key":"48539_CR84","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1021\/acs.analchem.8b02682","volume":"90","author":"K Mallah","year":"2018","unstructured":"Mallah, K. et al. Lipid changes associated with traumatic brain injury revealed by 3D MALDI-MSI. Anal. Chem. 90(17), 10568\u201310576 (2018).","journal-title":"Anal. Chem."},{"key":"48539_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11306-016-1131-5","volume":"12","author":"M Daley","year":"2016","unstructured":"Daley, M. et al. Metabolomics profiling of concussion in adolescent male hockey players: A novel diagnostic method. Metabolomics 12, 5 (2016).","journal-title":"Metabolomics"},{"issue":"12","key":"48539_CR86","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1089\/neu.2020.7125","volume":"38","author":"MR Miller","year":"2021","unstructured":"Miller, M. R. et al. Concussion acutely decreases plasma glycerophospholipids in adolescent male athletes. J. Neurotrauma 38(12), 1608\u20131614 (2021).","journal-title":"J. Neurotrauma"},{"issue":"1","key":"48539_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","volume":"106","author":"AA Farooqui","year":"2000","unstructured":"Farooqui, A. A., Horrocks, L. A. & Farooqui, T. Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106(1), 1\u201329 (2000).","journal-title":"Chem. Phys. Lipids"},{"issue":"4S Suppl","key":"48539_CR88","doi-asserted-by":"publisher","first-page":"1007s","DOI":"10.1093\/jn\/130.4.1007S","volume":"130","author":"BS Meldrum","year":"2000","unstructured":"Meldrum, B. S. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J. Nutr. 130(4S Suppl), 1007s\u20131015s (2000).","journal-title":"J. Nutr."},{"issue":"23","key":"48539_CR89","doi-asserted-by":"publisher","first-page":"12930","DOI":"10.3390\/ijms222312930","volume":"22","author":"M Moriel-Carretero","year":"2021","unstructured":"Moriel-Carretero, M. The many faces of lipids in genome stability (and how to unmask them). Int. J. Mol. Sci. 22(23), 12930 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6855","key":"48539_CR90","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/35097089","volume":"413","author":"D Panikashvili","year":"2001","unstructured":"Panikashvili, D. et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413(6855), 527\u2013531 (2001).","journal-title":"Nature"},{"issue":"4","key":"48539_CR91","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.jcbfm.9600047","volume":"25","author":"D Panikashvili","year":"2005","unstructured":"Panikashvili, D. et al. CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. J. Cereb. Blood Flow Metab. 25(4), 477\u2013484 (2005).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"8","key":"48539_CR92","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/jcbfm.2013.75","volume":"33","author":"A Cohen-Yeshurun","year":"2013","unstructured":"Cohen-Yeshurun, A. et al. N-Arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury. J. Cereb. Blood Flow Metab. 33(8), 1242\u20131250 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"48539_CR93","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/cells11091409","volume":"11","author":"A Taraskina","year":"2022","unstructured":"Taraskina, A. et al. Effects of traumatic brain injury on the gut microbiota composition and serum amino acid profile in rats. Cells 11(9), 1409 (2022).","journal-title":"Cells"},{"issue":"2","key":"48539_CR94","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SHK.0000000000001211","volume":"52","author":"SE Nicholson","year":"2019","unstructured":"Nicholson, S. E. et al. Moderate traumatic brain injury alters the gastrointestinal microbiome in a time-dependent manner. Shock 52(2), 240\u2013248 (2019).","journal-title":"Shock"},{"key":"48539_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2016.04.003","volume":"57","author":"A Houlden","year":"2016","unstructured":"Houlden, A. et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav. Immun. 57, 10\u201320 (2016).","journal-title":"Brain Behav. Immun."},{"key":"48539_CR96","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3389\/fimmu.2018.02757","volume":"9","author":"TJ Treangen","year":"2018","unstructured":"Treangen, T. J. et al. Traumatic brain injury in mice induces acute bacterial dysbiosis within the fecal microbiome. Front. Immunol. 9, 2757 (2018).","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"48539_CR97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/neu.2020.7526","volume":"39","author":"W You","year":"2022","unstructured":"You, W. et al. Traumatic brain injury induces gastrointestinal dysfunction and dysbiosis of gut microbiota accompanied by alterations of bile acid profile. J. Neurotrauma 39(1\u20132), 227\u2013237 (2022).","journal-title":"J. Neurotrauma"},{"key":"48539_CR98","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","volume":"9","author":"ON Kokiko-Cochran","year":"2018","unstructured":"Kokiko-Cochran, O. N. & Godbout, J. P. The inflammatory continuum of traumatic brain injury and Alzheimer\u2019s disease. Front. Immunol. 9, 672 (2018).","journal-title":"Front. Immunol."},{"issue":"18","key":"48539_CR99","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1089\/neu.2012.2575","volume":"29","author":"M Peters","year":"2012","unstructured":"Peters, M. et al. Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice. J. Neurotrauma 29(18), 2831\u20132834 (2012).","journal-title":"J. Neurotrauma"},{"key":"48539_CR100","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fnins.2018.00893","volume":"12","author":"JO Ojo","year":"2018","unstructured":"Ojo, J. O. et al. Disruption in brain phospholipid content in a humanized tau transgenic model following repetitive mild traumatic brain injury. Front. Neurosci. 12, 893 (2018).","journal-title":"Front. Neurosci."},{"issue":"2","key":"48539_CR101","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0009-3084(96)02580-7","volume":"81","author":"K Lohner","year":"1996","unstructured":"Lohner, K. Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? Chem. Phys. Lipids 81(2), 167\u2013184 (1996).","journal-title":"Chem. Phys. Lipids"},{"issue":"5","key":"48539_CR102","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuint.2005.12.001","volume":"48","author":"JH Yi","year":"2006","unstructured":"Yi, J. H. & Hazell, A. S. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem. Int. 48(5), 394\u2013403 (2006).","journal-title":"Neurochem. Int."},{"issue":"5","key":"48539_CR103","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s10143-022-01827-y","volume":"45","author":"SZY Ooi","year":"2022","unstructured":"Ooi, S. Z. Y. et al. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: A systematic review. Neurosurg. Rev. 45(5), 3035\u20133054 (2022).","journal-title":"Neurosurg. Rev."},{"issue":"2","key":"48539_CR104","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/JSM.0000000000000720","volume":"29","author":"KG Harmon","year":"2019","unstructured":"Harmon, K. G. et al. American Medical Society for sports medicine position statement on concussion in sport. Clin. J. Sport Med. 29(2), 87\u2013100 (2019).","journal-title":"Clin. J. Sport Med."},{"issue":"4","key":"48539_CR105","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","volume":"9","author":"H Zetterberg","year":"2013","unstructured":"Zetterberg, H., Smith, D. H. & Blennow, K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat. Rev. Neurol. 9(4), 201\u2013210 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"48539_CR106","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1523\/ENEURO.0294-16.2016","volume":"3","author":"H Adrian","year":"2016","unstructured":"Adrian, H. et al. Biomarkers of traumatic brain injury: Temporal changes in body fluids. eNeuro 3, 6 (2016).","journal-title":"eNeuro"},{"key":"48539_CR107","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fneur.2016.00172","volume":"7","author":"SA Dambinova","year":"2016","unstructured":"Dambinova, S. A. et al. Functional, structural, and neurotoxicity biomarkers in integrative assessment of concussions. Front. Neurol. 7, 172 (2016).","journal-title":"Front. Neurol."},{"key":"48539_CR108","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fneur.2012.00107","volume":"3","author":"DV Agoston","year":"2012","unstructured":"Agoston, D. V. & Elsayed, M. Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Front. Neurol. 3, 107 (2012).","journal-title":"Front. Neurol."},{"key":"48539_CR109","doi-asserted-by":"publisher","DOI":"10.22237\/jmasm\/1257035100","volume-title":"New Effect Size Rules of Thumb","author":"S Sawilowsky","year":"2009","unstructured":"Sawilowsky, S. New Effect Size Rules of Thumb (Theor. Behav. Found. Educ. Fac Publ., 2009)."},{"issue":"10","key":"48539_CR110","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/neu.1996.13.557","volume":"13","author":"Y Chen","year":"1996","unstructured":"Chen, Y. et al. An experimental model of closed head injury in mice: Pathophysiology, histopathology, and cognitive deficits. J. Neurotrauma 13(10), 557\u2013568 (1996).","journal-title":"J. Neurotrauma"},{"issue":"12","key":"48539_CR111","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1096\/fj.05-3907fje","volume":"19","author":"I Yatsiv","year":"2005","unstructured":"Yatsiv, I. et al. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. Faseb J. 19(12), 1701\u20131703 (2005).","journal-title":"Faseb J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48539-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48539-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48539-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T19:07:43Z","timestamp":1702580863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48539-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48539-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22260"}}